Efficacy of formoterol Turbuhaler in the emergency treatment of patients with obstructive airway diseases

Respiratory Medicine

Volumn 102, Issue 4, 2008, Pages 579-585

  van den Broek, Kristien M ^a   Wielders, Pascal L M L ^a   Creemers, Jacques P H M ^a   Smeenk, Frank W J M ^a  

^a CATHARINA HOSPITAL   (Netherlands)

Author keywords

Acute exacerbation of COPD; Bronchoconstriction; Dyspnoea; Pressurised metered dose inhaler; Turbuhaler

Indexed keywords

FORMOTEROL;

AGED; ARTICLE; BRONCHOSPASM; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE EXACERBATION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRY POWDER; DYSPNEA; EMERGENCY TREATMENT; EMERGENCY WARD; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; OBSTRUCTIVE AIRWAY DISEASE; PATIENT CARE; POWDER INHALER; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; STATISTICAL SIGNIFICANCE;

EID: 40049092585     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2007.11.009     Document Type: Article

References (23)

1. Global Initiative for Asthma (GINA) Report. Establish medical plans for long-term asthma management in adults. Global strategy for asthma management and prevention . NIH publication Number 02-3659. Updated 2005 form the 2004 document 〈 http://www.ginasthma.org 〉 (accessed 16 December 2006).
2. R.A. Pauwels A.S. Buist P.M.A. Calverley C.R. Jenkins S.S. Hurd Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO global initiative for chronic obstructive lung disease (GOLD) workshop summary Am J Respir Crit Care Med 163 5 2001 1256 1276
3. M.E.A.C. Broeders J. Molema W.C.J. Hop N.A. Vermue H.T.H. Folgering The course of inhalation profiles during an exacerbation of obstructive lung disease Respir Med 98 12 2004 1173 1179
4. ® as a rescue therapy compared with salbutamol pMDI plus a spacer in patients with acute severe asthma Respir Med 97 7 2003 1067 1074
5. A.R. Rubinfeld R. Scicchitano A. Hunt P.J. Thompson A. Van Nooten O. Selroos Formoterol Turbuhaler as reliever medication in patients with acute asthma Eur Respir J 27 4 2006 735 741
6. ® in chronic obstructive airways disease Respir Med 93 5 1999 342 344
7. P.H. Brown A.C. Ning A.P. Greening A. McLean G.K. Crompton Peak inspiratory flow through Turbuhaler in acute asthma Eur Respir J 8 11 1995 1940 1941
8. M.J. Politiek M. Boorsma R. Aalbers Comparison of formoterol, salbutamol and salmeterol in methacholine-induced severe bronchoconstriction Eur Respir J 13 5 1999 988 992
9. M. Cazzola S. Centanni C. Regorda F. Di Marco F. di Perna P. Carlucci Onset of action of single doses of formoterol administered via Turbuhaler in patients with stable COPD Pulm Pharmacol Ther 14 2001 41 45
10. M. Palmqvist G. Persson L. Lazer J. Rosenborg P. Larsson J. Lotvall Inhaled dry powder formoterol and salmeterol in asthmatic patients: onset of action, duration of effect and potency Eur Respir J 10 1997 2484 2489
11. A.E. Tattersfield C.G. Lofdahl D.S. Postma A. Eivindson A.G. Schreurs A. Rasidakis Comparison of formoterol and terbutaline for as-needed treatment of asthma: a randomised trial Lancet 357 9252 2001 257 261
12. R.A. Pauwels M.R. Sears M. Campbell C. Villasante S. Huang A. Lindh Formoterol as relief medication in asthma: a worldwide safety and effectiveness trial Eur Respir J 22 5 2003 787 794
13. D. Cheung H.C.J. van Klink R. Aalbers For the OZON Study Group. Improved lung function and symptom control with formoterol on demand in asthma Eur Respir J 27 3 2006 504 510
14. M. Campbell A. Eliraz G. Johansson G. Tornling U. Nihlen T. Bengtsson Formoterol for maintenance and as-needed treatment of chronic obstructive pulmonary disease Respir Med 99 12 2005 1511 1520
15. H.J. Van der Woude J. Zaagsma D.S. Postma T.H. Winter M. van Hulst R. Aalbers Detrimental effects of beta-blockers in COPD: a concern for nonselective beta-blockers Chest 127 3 2005 818 824
16. P.H.H. Quanjer G.J. Tammeling J.E. Cotes O.F. Pedersen R. Peslin J.C. Yernault Lung volumes and forced ventilatory flows, report working party: Standardisation of lung function tests European community for steel and coal. Official statement of the European respiratory society Eur Respir J 6 16 1993 5 40
17. G.A. Borg Psychophysical bases of perceived exertion Med Sci Sports Exerc 14 5 1982 377 381
18. EMEA. Guideline on the choice of the non-inferiority margin . London, 27 July 2005 〈 http://www.emea.eu.int/pdfs/human/ewp/215899en.pdf 〉, 15-06-2006 Ref Type: Internet Communication.
19. E. Derom L. Borgström J. Van Schoor A.B. Lofroos R.A. Pauwels Lung deposition and protective effect of terbutaline delivered from pressurized metered-dose inhalers and the Turbuhaler in asthmatic individuals Am J Respir Crit Care Med 164 8 2001 1398 1402
20. B.L.P. Maessen C.J.J. Westermann V.A.M. Duurkens J.M.M. Bosch van den Effects of formoterol in apparently poorly reversible chronic obstructive pulmonary disease Eur Respir J 13 1999 1103 1108
21. M. Cazzola M. D’Amato C. Califano F. di Perna F. Calderaro M.G. Matera Formoterol as dry powder oral inhalation compared with salbutamol metered-dose inhaler in acute exacerbations of chronic obstructive pulmonary disease Clin Ther 24 4 2002 595 604
22. V. Bellia S. Battaglia M.G. Matera M. Cazzola The use of bronchodilators in the treatment of airway obstruction in elderly patients Pulm Pharmacol Ther 19 2006 311 319
23. P.M. O’Byrne H. Bisgaard P.P. Godard M. Pistolesi M. Palmqvist Y. Zhu Budesonide/formoterol combination therapy as both maintenance and reliever medication in asthma Am J Respir Crit Care 171 2005 129 136